# Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger

> **NCT01755559** · PHASE4 · COMPLETED · sponsor: **Epicentre** · enrollment: 663 (actual)

## Conditions studied

- Malaria

## Interventions

- **DRUG:** Artesunate-amodiaquine
- **DRUG:** Dihydroartemisinin-piperaquine
- **DRUG:** Artemether-lumefantrine

## Key facts

- **NCT ID:** NCT01755559
- **Lead sponsor:** Epicentre
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 663 (ACTUAL)
- **Last updated:** 2015-11-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01755559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01755559, "Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01755559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*